Sun Pharma Advanced Research Company Limited SPARC.NS Stock
Sun Pharma Advanced Research Company Limited Price Chart
Sun Pharma Advanced Research Company Limited SPARC.NS Financial and Trading Overview
Contents
- Sun Pharma Advanced Research Company Limited Price Chart
- Sun Pharma Advanced Research Company Limited SPARC.NS Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Sun Pharma Advanced Research Company Limited
- Q&A For Sun Pharma Advanced Research Company Limited Stock
| Sun Pharma Advanced Research Company Limited stock price | 212.05 INR |
| Previous Close | 192 INR |
| Open | 193 INR |
| Bid | 199.15 INR x 0 |
| Ask | 199.3 INR x 0 |
| Day's Range | 192.25 - 199.55 INR |
| 52 Week Range | 162.1 - 265.85 INR |
| Volume | 867.68K INR |
| Avg. Volume | 980.9K INR |
| Market Cap | 64.76B INR |
| Beta (5Y Monthly) | 0.702739 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -11.94 INR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 1125 INR |
SPARC.NS Valuation Measures
| Enterprise Value | 57.87B INR |
| Trailing P/E | N/A |
| Forward P/E | 4.6085453 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 27.120512 |
| Price/Book (mrq) | 12.512541 |
| Enterprise Value/Revenue | 24.234 |
| Enterprise Value/EBITDA | -27.032 |
Trading Information
Sun Pharma Advanced Research Company Limited Stock Price History
| Beta (5Y Monthly) | 0.702739 |
| 52-Week Change | 3.69% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 265.85 INR |
| 52 Week Low | 162.1 INR |
| 50-Day Moving Average | 191.25 INR |
| 200-Day Moving Average | 208.18 INR |
SPARC.NS Share Statistics
| Avg. Volume (3 month) | 980.9K INR |
| Avg. Daily Volume (10-Days) | 247.21K INR |
| Shares Outstanding | 324.52M |
| Float | 92.33M |
| Short Ratio | N/A |
| % Held by Insiders | 64.89% |
| % Held by Institutions | 1.40% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | -93.21% |
| Operating Margin (ttm) | -94.57% |
| Gross Margin | 90.73% |
| EBITDA Margin | -89.64% |
Management Effectiveness
| Return on Assets (ttm) | -25.42% |
| Return on Equity (ttm) | -81.83% |
Income Statement
| Revenue (ttm) | 2.39B INR |
| Revenue Per Share (ttm) | 8.39 INR |
| Quarterly Revenue Growth (yoy) | 89.00% |
| Gross Profit (ttm) | N/A |
| EBITDA | -2140600064 INR |
| Net Income Avi to Common (ttm) | -2225799936 INR |
| Diluted EPS (ttm) | -7.85 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 4.02B INR |
| Total Cash Per Share (mrq) | 12.52 INR |
| Total Debt (mrq) | 156.7M INR |
| Total Debt/Equity (mrq) | 3.06 INR |
| Current Ratio (mrq) | 2.542 |
| Book Value Per Share (mrq) | 15.948 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -691200000 INR |
| Levered Free Cash Flow (ttm) | -625113984 INR |
Profile of Sun Pharma Advanced Research Company Limited
| Country | India |
| State | N/A |
| City | Mumbai |
| Address | 17-B, Mahal Industrial Estate |
| ZIP | 400093 |
| Phone | 91 22 6645 5645 |
| Website | https://www.sparc.life |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Sun Pharma Advanced Research Company Limited, a biopharmaceutical company, engages in the research and development of pharmaceutical products in India and internationally. It develops new chemical and biological entities, and reformulated products with a therapeutic focus on oncology, neurodegeneration, ophthalmology, dermatology, and Immunology. The company offers Elepsia, a formulation of levetiracetam that is an anti-epileptic agent to treat epilepsy disorder; and Xelpros, a latanoprost ophthalmic emulsion for the treatment of open-angle glaucoma or ocular hypertension. In addition, it is developing SDN-037, a formulation of difluprednate for the treatment of inflammation and pain associated with ocular surgery that is in phase 3 clinical trial; PDP-716 to treat glaucoma, which is in phase 3 clinical trial; phenobarbital sodium for the treatment of neonatal seizures; Vodobatinib (SCO-088) for the treatment of resistant chronic myelogenous leukemia that has completed a part A of the Phase 1 study; Vodobatinib (SCC-138), which is in phase 2 clinical trial to treat Parkinson's disease; SCD-044 for the treatment of psoriasis and atopic dermatitis that is in phase 2 clinical trial; and SCO-120 for the treatment of hormone receptor-positive, human epidermal receptor 2 negative, and metastatic breast cancer, which is in phase 1 clinical trial. Sun Pharma Advanced Research Company Limited has a collaboration agreement with Bioprojet to develop an S1P receptor 1 agonist for autoimmune disorders. The company was incorporated in 2006 and is based in Mumbai, India. Sun Pharma Advanced Research Company Limited is a subsidiary of Shanghvi Finance Private Limited.
Q&A For Sun Pharma Advanced Research Company Limited Stock
What is a current SPARC.NS stock price?
Sun Pharma Advanced Research Company Limited SPARC.NS stock price today per share is 212.05 INR.
How to purchase Sun Pharma Advanced Research Company Limited stock?
You can buy SPARC.NS shares on the NSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Sun Pharma Advanced Research Company Limited?
The stock symbol or ticker of Sun Pharma Advanced Research Company Limited is SPARC.NS.
Which industry does the Sun Pharma Advanced Research Company Limited company belong to?
The Sun Pharma Advanced Research Company Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Sun Pharma Advanced Research Company Limited have in circulation?
The max supply of Sun Pharma Advanced Research Company Limited shares is 324.52M.
What is Sun Pharma Advanced Research Company Limited Price to Earnings Ratio (PE Ratio)?
Sun Pharma Advanced Research Company Limited PE Ratio is now.
What was Sun Pharma Advanced Research Company Limited earnings per share over the trailing 12 months (TTM)?
Sun Pharma Advanced Research Company Limited EPS is -11.94 INR over the trailing 12 months.
Which sector does the Sun Pharma Advanced Research Company Limited company belong to?
The Sun Pharma Advanced Research Company Limited sector is Healthcare.
Sun Pharma Advanced Research Company Limited SPARC.NS included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| Nasdaq EM Plus Korea Small Cap NQEMKRSCGBP | 1476.35 GBP 1888.16 USD |
<0.01
|
— — | 1476.35 GBP 1888.16 USD | 1476.35 GBP 1888.16 USD | — - | — — |
- {{ link.label }} {{link}}